NewBio achieves IVDR compliance for TPHA and RPR products
This ensures enhanced safety, performance, traceability, and future-ready regulatory alignment for laboratories worldwide.
See the latest news and media coverage for NewBio. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of syphilis IVD reagents and test kits
new-bio.comLast updated
In short: NewBio achieved IVDR compliance, expanded its global reach through Australian registration, and maintained critical quality certifications.
This ensures enhanced safety, performance, traceability, and future-ready regulatory alignment for laboratories worldwide.
Position in Newmarket offers £24–26k pro-rata for 22.5 hours weekly, with potential increase.
The role supports production and quality control of in-vitro diagnostic reagents in Kentford, Newmarket. Applications close 28/02/2026.
The kit is now listed on the Australian Register of Therapeutic Goods (ARTG: 458113). NewBio thanks Southern Cross Diagnostics for support in delivering diagnostic solutions to Australia.
Track NewBio and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to NewBio and other trending companies.